Results 161 to 170 of about 70,782 (340)

A case of visceral leishmaniasis mimicking connective tissue disease

open access: yes
Rheumatology &Autoimmunity, EarlyView.
Yucui Li   +4 more
wiley   +1 more source

Daratumumab and isatuximab differentially affect CD38 detection on plasma cells in myeloma: Anti‐CD38 nanobody (clone JK36) and CD319 combination improve flow cytometric identification of plasma cells after targeted therapies

open access: yesBritish Journal of Haematology, EarlyView.
Daratumumab and isatuximab differentially affect plasma cell identification by anti‐CD38 detection antibodies. HB‐7 and JK36 bind to CD38 epitopes E1 and E3, respectively, and co‐staining of plasma cells in the absence of CD38‐directed drugs results in a diagonal staining pattern (top left).
Afshin Shameli   +5 more
wiley   +1 more source

Immunophenotyping using gold or silver nanoparticle-polystyrene bead conjugates with multiple light scatter [PDF]

open access: bronze, 2000
Olavi Siiman   +4 more
openalex   +1 more source

Immunophenotyping of Patients With Rheumatoid Arthritis Reveals Difference in CD27<sup>+</sup>IgD<sup>+</sup> Unswitched Memory B Cell Profiles. [PDF]

open access: yesMediators Inflamm
Hansen B   +21 more
europepmc   +1 more source

Immunophenotyping of ex vivo expanded CD34+ cells from cord blood [PDF]

open access: bronze, 2000
Laura Porretti   +8 more
openalex   +1 more source

Distinct patient, tumour and chimeric antigen receptor T‐cell characteristics are associated with initiating versus sustaining responses to idecabtagene vicleucel in relapsed and refractory multiple myeloma

open access: yesBritish Journal of Haematology, EarlyView.
Translational analyses from the KarMMa trial (NCT03361748) highlight that baseline tumour burden, immune environment and chimeric antigen receptor (CAR) T‐cell dynamics influence both the initiation and durability of response to idecabtagene vicleucel (ide‐cel) in relapsed and refractory multiple myeloma.
Nathan Martin   +13 more
wiley   +1 more source

5q deletion in childhood T-acute lymphoblastic leukemia at diagnosis: a case report. [PDF]

open access: yesJ Med Case Rep
Sbibih Y   +6 more
europepmc   +1 more source

The ?typical? immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant? [PDF]

open access: bronze, 2000
Markus Exner   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy